PHASE II: ADAPTIVE TREATMENT DE-ESCALATION IN FAVORABLE RISK HPV-POSITIVE OROPHARYNGEAL CARCINOMA

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Head And Neck Cancer
  • Age: Between 18 Year(s) - 100 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:

    1.  Patients must have pathologically (histological or cytological) proven diagnosis of squamous cell carcinoma of the oropharynx, which includes the site tonsil, base of the tongue, soft palate, or posterior oropharyngeal wall.

     

You may not be eligible for this study if the following are true:

  • 1.  Patients with cancers considered to be from an oral cavity site (oral tongue, floor of mouth, alveolar ridge, buccal or lip), or the nasopharynx, hypopharyhnx, or larynx (even if p16 positive)

     

    2.  Patients with carcinoma



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.